MedX Health Corp (MDXHF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 185.62 Thousand CAD | -22.77% |
| 2022 | 4.1 Million CAD | -15.33% |
| 2021 | 4.85 Million CAD | 47.15% |
| 2020 | 3.29 Million CAD | -8.66% |
| 2019 | 3.61 Million CAD | -24.38% |
| 2018 | 4.77 Million CAD | 126.4% |
| 2017 | 2.1 Million CAD | 27.18% |
| 2016 | 1.65 Million CAD | 23.43% |
| 2015 | 1.34 Million CAD | 28.84% |
| 2014 | 1.04 Million CAD | -15.43% |
| 2013 | 1.23 Million CAD | -29.58% |
| 2012 | 1.75 Million CAD | 30.25% |
| 2011 | 1.34 Million CAD | -4.37% |
| 2010 | 1.4 Million CAD | -39.3% |
| 2009 | 2.31 Million CAD | -34.22% |
| 2008 | 3.51 Million CAD | 25.7% |
| 2007 | 2.8 Million CAD | -17.99% |
| 2006 | 3.41 Million CAD | -15.19% |
| 2005 | 4.02 Million CAD | 56.95% |
| 2004 | 2.56 Million CAD | 25.61% |
| 2003 | 2.04 Million CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 791.36 Thousand CAD | 2.16% |
| 2024 Q1 | 774.66 Thousand CAD | 24.36% |
| 2023 FY | 3.17 Million CAD | -22.77% |
| 2023 Q4 | 622.93 Thousand CAD | -30.8% |
| 2023 Q2 | 886.89 Thousand CAD | 11.92% |
| 2023 Q1 | 792.46 Thousand CAD | -27.47% |
| 2023 Q3 | 900.15 Thousand CAD | 1.49% |
| 2022 FY | 4.1 Million CAD | -15.33% |
| 2022 Q2 | 1.09 Million CAD | 9.15% |
| 2022 Q4 | 1.09 Million CAD | 19.53% |
| 2022 Q1 | 1 Million CAD | -21.63% |
| 2022 Q3 | 914.08 Thousand CAD | -16.66% |
| 2021 FY | 4.85 Million CAD | 47.15% |
| 2021 Q4 | 1.28 Million CAD | -7.78% |
| 2021 Q1 | 984.76 Thousand CAD | 29.07% |
| 2021 Q2 | 1.19 Million CAD | 21.36% |
| 2021 Q3 | 1.39 Million CAD | 16.32% |
| 2020 FY | 3.29 Million CAD | -8.66% |
| 2020 Q1 | 652.62 Thousand CAD | -47.64% |
| 2020 Q4 | 762.99 Thousand CAD | -33.83% |
| 2020 Q2 | 714.94 Thousand CAD | 9.55% |
| 2020 Q3 | 1.15 Million CAD | 61.29% |
| 2019 Q2 | 833.84 Thousand CAD | -0.97% |
| 2019 Q3 | 690.49 Thousand CAD | -17.19% |
| 2019 FY | 3.61 Million CAD | -24.38% |
| 2019 Q4 | 1.24 Million CAD | 80.51% |
| 2019 Q1 | 842.05 Thousand CAD | -30.24% |
| 2018 Q3 | 1 Million CAD | -44.43% |
| 2018 Q4 | 1.2 Million CAD | 20.61% |
| 2018 FY | 4.77 Million CAD | 126.4% |
| 2018 Q1 | 764.88 Thousand CAD | 69.73% |
| 2018 Q2 | 1.8 Million CAD | 135.48% |
| 2017 Q4 | 450.63 Thousand CAD | -33.08% |
| 2017 Q1 | 470.04 Thousand CAD | 60.02% |
| 2017 Q2 | 514.54 Thousand CAD | 9.47% |
| 2017 FY | 2.1 Million CAD | 27.18% |
| 2017 Q3 | 673.43 Thousand CAD | 30.88% |
| 2016 Q2 | 401.4 Thousand CAD | 22.94% |
| 2016 Q1 | 326.51 Thousand CAD | -32.33% |
| 2016 Q3 | 637.26 Thousand CAD | 58.76% |
| 2016 FY | 1.65 Million CAD | 23.43% |
| 2016 Q4 | 293.74 Thousand CAD | -53.91% |
| 2015 FY | 1.34 Million CAD | 28.84% |
| 2015 Q1 | 223.74 Thousand CAD | -54.41% |
| 2015 Q4 | 482.48 Thousand CAD | 53.61% |
| 2015 Q3 | 314.09 Thousand CAD | -2.63% |
| 2015 Q2 | 322.56 Thousand CAD | 44.17% |
| 2014 FY | 1.04 Million CAD | -15.43% |
| 2014 Q3 | -185.38 Thousand CAD | -144.21% |
| 2014 Q2 | 419.35 Thousand CAD | 31.94% |
| 2014 Q1 | 317.83 Thousand CAD | 82.72% |
| 2014 Q4 | 490.76 Thousand CAD | 364.72% |
| 2013 Q1 | 362.67 Thousand CAD | -16.47% |
| 2013 Q4 | 173.94 Thousand CAD | -60.81% |
| 2013 FY | 1.23 Million CAD | -29.58% |
| 2013 Q2 | 252.26 Thousand CAD | -30.44% |
| 2013 Q3 | 443.85 Thousand CAD | 75.95% |
| 2012 FY | 1.75 Million CAD | 30.25% |
| 2012 Q4 | 434.2 Thousand CAD | 3.08% |
| 2012 Q3 | 421.21 Thousand CAD | -6.71% |
| 2012 Q2 | 451.51 Thousand CAD | 2.63% |
| 2012 Q1 | 439.94 Thousand CAD | 6.05% |
| 2011 Q4 | 414.82 Thousand CAD | 12.03% |
| 2011 Q2 | 280.48 Thousand CAD | 0.71% |
| 2011 Q1 | 278.5 Thousand CAD | -31.68% |
| 2011 FY | 1.34 Million CAD | -4.37% |
| 2011 Q3 | 370.28 Thousand CAD | 32.02% |
| 2010 Q1 | 353.68 Thousand CAD | -48.59% |
| 2010 FY | 1.4 Million CAD | -39.3% |
| 2010 Q2 | 312.05 Thousand CAD | -11.77% |
| 2010 Q3 | 392.78 Thousand CAD | 25.87% |
| 2010 Q4 | 407.67 Thousand CAD | 3.79% |
| 2009 Q2 | 567.95 Thousand CAD | -13.81% |
| 2009 Q1 | 658.95 Thousand CAD | -21.65% |
| 2009 FY | 2.31 Million CAD | -34.22% |
| 2009 Q3 | 400.55 Thousand CAD | -29.47% |
| 2009 Q4 | 687.9 Thousand CAD | 71.74% |
| 2008 Q4 | 841.01 Thousand CAD | 1.67% |
| 2008 Q3 | 827.2 Thousand CAD | -18.52% |
| 2008 Q1 | 836.34 Thousand CAD | 11.02% |
| 2008 Q2 | 1.01 Million CAD | 21.39% |
| 2008 FY | 3.51 Million CAD | 25.7% |
| 2007 Q2 | 752.93 Thousand CAD | -2.91% |
| 2007 Q1 | 775.53 Thousand CAD | -22.97% |
| 2007 Q3 | 517.51 Thousand CAD | -31.27% |
| 2007 Q4 | 753.36 Thousand CAD | 45.57% |
| 2007 FY | 2.8 Million CAD | -17.99% |
| 2006 Q2 | 735.4 Thousand CAD | -1.68% |
| 2006 Q1 | 747.99 Thousand CAD | -50.55% |
| 2006 FY | 3.41 Million CAD | -15.19% |
| 2006 Q3 | 934.81 Thousand CAD | 27.12% |
| 2006 Q4 | 1 Million CAD | 7.71% |
| 2005 Q4 | 1.51 Million CAD | 68.05% |
| 2005 FY | 4.02 Million CAD | 56.95% |
| 2005 Q1 | 742.68 Thousand CAD | -7.18% |
| 2005 Q2 | 870.15 Thousand CAD | 17.16% |
| 2005 Q3 | 900.11 Thousand CAD | 3.44% |
| 2004 FY | 2.56 Million CAD | 25.61% |
| 2004 Q1 | 507.22 Thousand CAD | 0.0% |
| 2004 Q3 | 651.91 Thousand CAD | 8.32% |
| 2004 Q4 | 800.1 Thousand CAD | 22.73% |
| 2004 Q2 | 601.82 Thousand CAD | 18.65% |
| 2003 FY | 2.04 Million CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | 703 Thousand USD | 73.595% |
| Össur hf. | 396.18 Million USD | 99.953% |
| QHSLab, Inc. | 961.65 Thousand USD | 80.697% |
| Wellstar International, Inc. | 1.79 Million USD | 89.657% |
| Össur hf. | 396.18 Million USD | 99.953% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 5.25 Million USD | 96.465% |
| Aurora Spine Corporation | 8.65 Million USD | 97.856% |
| BrainsWay Ltd. | 28.01 Million USD | 99.337% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| AVITA Medical, Inc. | 80.77 Million USD | 99.77% |
| CVR Medical Corp. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 33.57 Million USD | 99.447% |
| BioElectronics Corporation | 740.67 Thousand USD | 74.938% |
| Vivos Inc. | 2.78 Million USD | 93.34% |
| Kelyniam Global, Inc. | 2.27 Million USD | 91.841% |
| Zecotek Photonics Inc. | 3.46 Million USD | 94.637% |
| REMSleep Holdings, Inc. | 1.01 Million USD | 81.71% |
| EKF Diagnostics Holdings plc | 21.77 Million USD | 99.148% |
| Avitar, Inc. | 3.56 Million USD | 94.8% |
| Nanomix Corporation | 8.36 Million USD | 97.782% |
| Theraclion SA | 7.43 Million USD | 97.505% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 1.29 Million USD | 85.661% |
| NewCardio, Inc. | 9.56 Million USD | 98.059% |
| Positron Corporation | 1 Million USD | 81.571% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.11 Million USD | 94.032% |
| Lombard Medical, Inc. | 30.29 Million USD | 99.387% |
| ALR Technologies Inc. | 6.33 Million USD | 97.07% |
| Stratec SE | 46.32 Million USD | 99.599% |
| Vycor Medical, Inc. | 1.27 Million USD | 85.446% |
| Heart Tronics, Inc. | 14.46 Million USD | 98.716% |
| Nu-Med Plus, Inc. | 120.52 Thousand USD | -54.015% |
| MicroPort Scientific Corporation | 1.04 Billion USD | 99.982% |
| VMS Rehab Systems, Inc. | 63.63 USD | -291630.316% |
| Guided Therapeutics, Inc. | 3.49 Million USD | 94.686% |
| Ingen Technologies, Inc. | 1.88 Million USD | 90.138% |
| CYduct Diagnostics, Inc. | 435.5 Thousand USD | 57.376% |
| Odyssey Group International, Inc. | -14.26 Million USD | 101.302% |
| SANUWAVE Health, Inc. | 14.15 Million USD | 98.688% |
| IR-Med Inc. | 4.89 Million USD | 96.207% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | 10.072% |
| United American Healthcare Corporation | 59 Thousand USD | -214.624% |
| Polarean Imaging plc | 12.24 Million USD | 98.484% |
| ECGI Holdings, Inc. | 407.48 Thousand USD | 54.445% |
| Capital Group Holdings, Inc. | 634.68 Thousand USD | 70.753% |
| ADM Tronics Unlimited, Inc. | 1.69 Million USD | 89.052% |
| Medical Supply International USA, Inc. | 1.32 Million USD | 85.943% |
| Rapid Therapeutic Science Laboratories, Inc. | 1.26 Million USD | 85.306% |
| Nexeon MedSystems Inc. | 5.94 Million USD | 96.879% |
| SS Innovations International, Inc. | 21.38 Million USD | 99.132% |
| Urologix, Inc. | 10.09 Million USD | 98.161% |
| Qualis Innovations, Inc. | 230.24 Thousand USD | 19.377% |
| Smith & Nephew plc | 3.46 Billion USD | 99.995% |
| NIOX Group Plc | 22.27 Million USD | 99.167% |
| Fuse Medical, Inc. | 10.35 Million USD | 98.206% |
| Broncus Holding Corporation | 38.15 Million USD | 99.513% |
| Brain Scientific Inc. | 9.66 Million USD | 98.079% |
| Pressure BioSciences, Inc. | 10.3 Million USD | 98.198% |
| Health Logic Interactive Inc. | 60.69 Thousand USD | -205.822% |